Epstein-Barr Virus: Should We Still Invest in Vaccines or Focus on Predictive Tests?
The complex interplay between host and EBV has made it difficult to elaborate useful vaccines protecting against EBV diseases. It is encouraging to see that EBV vaccine programs have started to incorporate different arms of the immune system. An array of argument calls for a realistic goal for vacci...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/79166 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Epstein-Barr Virus: Should We Still Invest in Vaccines or Focus on Predictive Tests?
- Epstein-Barr Virus-Encoded miRNAs in Epstein-Barr Virus-Related Malignancy
- Vaccines and Antiviral Drugs for Diseases Associated with the Epstein-Barr Virus
- Ocular Manifestations in Epstein Barr Virus Infection
- Epstein-Barr Virus Serology in the Detection and Screening of Nasopharyngeal Carcinoma
- Epstein-Barr Virus-Associated Gastric Cancer: Old Entity with New Relevance
- Role of the Epstein-Barr Virus ZEBRA Protein and HPV in the Carcinogenesis of Nasopharyngeal Carcinoma